Keep up with all the latest news about how TEDCO is helping grow the Maryland entrepreneur funding sector through investments, network of industry professionals, and educational resources.
News & Events
TEDCO in the News
TEDCO’s First Round of Equitech Growth Fund Awardees Unveiled
TEDCO, Maryland’s economic engine for technology companies, announced the awardees for the first round of the new Equitech Growth Fund. A total of nearly $7 million will be distributed among the 14 projects located across Maryland. Of these awards, over $4.7 million will support six projects
LEARN MORE
Twelve companies recognized for their efforts to develop and promote green energy technologies
Winners of the USPTO’s 2024 Patents for Humanity and inaugural Trademarks for Humanity competitions are using their intellectual property to meet environmental and climate change challenges
LEARN MORE
19 tech and entrepreneurship events to check out before the holidays
TEDCO’s Entrepreneur Expo — “TEDCO’s 10th Entrepreneur Expo will be held Wednesday, Dec. 4, 2024 at the Renaissance Baltimore Harborplace Hotel. The Expo is a premier event in Maryland showcasing various resources from across the state and is jam-packed full of workshops, roundtable discussions
LEARN MORE
Meet Baltimore’s winners in the 2024 Technical.ly Awards
From leading ecosystem builders to a celebrated podcaster (who shared a surprise announcement), these winners helped local innovation shine.
LEARN MORE
Pagination
Press Releases
Maryland Innovation Initiative (MII) Board Meeting - March 20, 2025
Maryland Innovation Initiative (MII) Meeting Thursday, March 20, 2025 NOTICE is hereby given for a
LEARN MORE
TEDCO Announces Seeyew Mo as the Senior Advisor, Cyber Maryland
New hire to help leverage the nation’s epicenter for cybersecurity talent COLUMBIA, Md., (March 13
LEARN MORE
TEDCO Announces Concept Capital Funding to Pedestal
Company creating a platform where artists can create exclusive content for their fans COLUMBIA, Md
LEARN MORE
TEDCO Invests in Irazú Oncology
Life sciences company developing a cost-effective production process for cancer immunotherapies
LEARN MORE